RhythmAnalytics vs IM007

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

RhythmAnalytics specializes in AI-powered automated interpretation of cardiac arrhythmias from single-lead ECG data, providing clinical decision support. In contrast, IM007 is a comprehensive remote cardiac monitoring platform that aggregates data from various cardiac implantable electronic devices (CIEDs) to streamline workflows and manage alerts. While both leverage AI for cardiac analysis and are FDA-cleared, RhythmAnalytics focuses on ECG interpretation from external devices, whereas IM007 provides a broader solution for managing patients with implanted cardiac devices.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Frequently Asked Questions

RhythmAnalytics by Biofourmis is designed for automated interpretation of cardiac arrhythmias from single-lead ECG data, compatible with FDA-cleared ECG devices such as Holter monitors, event recorders, and wearable sensors. In contrast, Implicity's IM007 platform aggregates and analyzes data from all major cardiac implantable electronic devices (CIEDs), including those from Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
RhythmAnalytics primarily provides AI-powered automated interpretation of cardiac arrhythmias from ECG data to enhance clinical decision support for healthcare professionals. IM007 serves as a comprehensive AI-powered platform for remote cardiac monitoring, streamlining workflows, reducing false alerts, and improving patient outcomes in cardiology and heart failure management by aggregating CIED data.
RhythmAnalytics offers AI-based automated interpretation of over 15 types of cardiac arrhythmias from single-lead ECGs, including beat-by-beat morphology computation and QRS feature extraction. IM007's ILR ECG Analyzer provides FDA-cleared AI for Insertable Cardiac Monitor (ICM) ECG data analysis, and its AI-driven alert management significantly reduces false positives for various cardiac events, such as a 79% reduction for ILR ECG Analyzer and 85% for AF alerts.
RhythmAnalytics focuses on providing clinical decision support through automated ECG interpretation and can be integrated as a cloud-based API into existing cardiac monitoring solutions. IM007 offers smart workflow automation for billing, reporting, and scheduling, along with AI-driven alert management to reduce false positives and patient connectivity management for disconnected patients via automated SMS.
RhythmAnalytics is deployed as a cloud-based API, allowing for integration into various healthcare professional and integrator systems. IM007 is a cloud-based SaaS platform that offers bidirectional API and an integration framework for seamless EHR integration.
RhythmAnalytics focuses on arrhythmia interpretation and does not explicitly mention heart failure management features. IM007 includes SignalHF, an FDA-cleared predictive AI specifically designed to forecast the risk of heart failure hospitalization, making it particularly relevant for heart failure management.

Backers

Who funded each tool's parent company.

IM007

AI Tool Finder
AI-powered search. Results may not be comprehensive.